Search and analyze individual stocks with comprehensive metrics

Sharma E I Hosp.

SHARMEHHealthcare Services

Fundamental Score

...

Sharma E I Hosp. Share Price & Market Analysis

Current Market Price (CMP)
149.60
No change data available
Market Cap
55.63 (Cr)
Industry
Healthcare Services

Profitability Metrics

Poor

Return on Equity

10.46%
Poor

Return on Capital Employed

13.74%
Poor

Operating Profit Margin (5Y)

7.07%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

42.14x

Market Capitalization

55.63 (Cr)

Industry P/E

40.71x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

28.00%
Excellent

YoY Quarterly Sales Growth

40.92%
Excellent

Sales Growth (5Y)

13.06%

EPS Growth (5Y)

N/A
Excellent

Profit Growth (5Y)

31.95%

Financial Health

Excellent

Debt to Equity

0.18x
Excellent

Interest Coverage

3.32x
Average

Free Cash Flow (5Y)

9.10 (Cr)

Ownership Structure

Good

Promoter Holding

53.63%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
53.63%
Promoter Holding
55.63 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of SHARMEH across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Robust Profit Growth (28.00%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (40.92%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (13.06% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Strong Profit Growth Track Record (31.95% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Conservative Debt Levels (D/E: 0.18)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Balanced Promoter Holding (53.63%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

4 factors identified

Premium Valuation Risk (P/E: 42.14x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the Healthcare Service Provider sector...

Financial Statements

Comprehensive financial data for Sharma E I Hosp.

About SHARMEH

Company Details

Symbol:SHARMEH
Industry:Healthcare Services
Sector:Healthcare Service Provider

Market Information

Market Cap:55.63 (Cr)
P/E Ratio:42.14
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:0.00%

SHARMEH Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)10.46%
Return on Capital Employed13.74%
Operating Profit Margin (5Y)7.07%
Debt to Equity Ratio0.18
Interest Coverage Ratio3.32

Growth & Valuation

Sales Growth (5Y)13.06%
Profit Growth (5Y)31.95%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth28.00%
YoY Quarterly Sales Growth40.92%

Frequently Asked Questions

What is the current price of SHARMEH?

SHARMEH is currently trading at ₹149.60 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of SHARMEH shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of SHARMEH and what does it mean?

SHARMEH has a P/E ratio of 42.14x compared to the industry average of 40.71x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹42 for every ₹1 of annual earnings. This is higher than the industry average, suggesting either growth premium or potential overvaluation.

How is SHARMEH performing according to Bull Run's analysis?

SHARMEH has a Bull Run fundamental score of 63.5/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 10.46%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does SHARMEH belong to?

SHARMEH operates in the Healthcare Services industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Sharma E I Hosp.. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for SHARMEH?

SHARMEH has an ROE of 10.46%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Sharma E I Hosp. generates profits from shareholders' equity. An ROE of 10% means the company generates ₹10 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is SHARMEH's debt-to-equity ratio and what does it indicate?

SHARMEH has a debt-to-equity ratio of 0.18, which indicates conservative financing with low financial risk. This means the company has ₹18 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is SHARMEH's dividend yield and is it a good dividend stock?

SHARMEH offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has SHARMEH grown over the past 5 years?

SHARMEH has achieved 5-year growth rates of: Sales Growth 13.06%, Profit Growth 31.95%, and EPS Growth N/A%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in SHARMEH and why does it matter?

Promoters hold 53.63% of SHARMEH shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.

How does SHARMEH compare with its industry peers?

SHARMEH trades at P/E 42.14x vs industry average 40.71x, with ROE of 10.46% and ROCE of 13.74%. The stock trades at a premium to industry average, which may be justified by superior fundamentals. Peer comparison helps identify whether SHARMEH is outperforming its competitive set in profitability, growth, and valuation metrics.

What is SHARMEH's market capitalization and what category does it fall into?

SHARMEH has a market capitalization of ₹56 crores, making it a Mid-cap stock. Mid-cap stocks balance growth potential with moderate risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for SHARMEH?

Key ratios for SHARMEH: ROE 10.46% (Good), ROCE 13.74%, P/E 42.14x, Debt-to-Equity 0.18, Interest Coverage 3.32x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is SHARMEH stock and what is its beta?

SHARMEH has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for SHARMEH?

SHARMEH has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹149.60, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in SHARMEH?

Key risks for SHARMEH include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.18), and operational challenges. The stock has a Fundamental Score of 63.5/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Healthcare Services include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is SHARMEH's operating profit margin and how has it trended?

SHARMEH has a 5-year average Operating Profit Margin (OPM) of 7.07%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is SHARMEH's quarterly performance in terms of sales and profit growth?

SHARMEH's recent quarterly performance shows YoY Sales Growth of 40.92% and YoY Profit Growth of 28.00%. This strong double-digit growth indicates excellent business momentum and management execution. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in SHARMEH?

SHARMEH has FII holding of 0.00% and DII holding of 0.00%, totaling 0.00% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.